Allergic asthma is caused by the aberrant expansion in the lung of T helper cells that produce type 2 (TH2) cytokines and is characterized by infiltration of eosinophils and bronchial hyperreactivity. This disease is often triggered by mast cells activated by immunoglobulin E (IgE)-mediated allergic challenge. Activated mast cells release various chemical mediators, including prostaglandin D2 (PGD2), whose role in allergic asthma has now been investigated by the generation of mice deficient in the PGD receptor (DP). Sensitization and aerosol challenge of the homozygous mutant (DP-/-) mice with ovalbumin (OVA) induced increases in the serum concentration of IgE similar to those in wild-type mice subjected to this model of asthma. However, the concentrations of TH2 cytokines and the extent of lymphocyte accumulation in the lung of OVA-challenged DP-/- mice were greatly reduced compared with those in wild-type animals. Moreover, DP-/- mice showed only marginal infiltration of eosinophils and failed to develop airway hyperreactivity. Thus, PGD2 functions as a mast cell-derived mediator to trigger asthmatic responses.
Caffeine, a component of tea, coffee and cola, induces wakefulness. It binds to adenosine A1 and A2A receptors as an antagonist, but the receptor subtype mediating caffeine-induced wakefulness remains unclear. Here we report that caffeine at 5, 10 and 15 mg kg(-1) increased wakefulness in both wild-type mice and A1 receptor knockout mice, but not in A2A receptor knockout mice. Thus, caffeine-induced wakefulness depends on adenosine A2A receptors.
Polyglutamine (polyQ) diseases are classified as conformational neurodegenerative diseases, like Alzheimer and Parkinson diseases, and they are caused by proteins with an abnormally expanded polyQ stretch. However, conformational changes of the expanded polyQ protein and the toxic conformers formed during aggregation have remained poorly understood despite their important role in pathogenesis. Here we show that a beta-sheet conformational transition of the expanded polyQ protein monomer precedes its assembly into beta-sheet-rich amyloid-like fibrils. Microinjection of the various polyQ protein conformers into cultured cells revealed that the soluble beta-sheet monomer causes cytotoxicity. The polyQ-binding peptide QBP1 prevents the toxic beta-sheet conformational transition of the expanded polyQ protein monomer. We conclude that the toxic conformational transition, and not simply the aggregation process itself, is a therapeutic target for polyQ diseases and possibly for conformational diseases in general.
Orexin neurons are exclusively localized in the lateral
hypothalamic area and project their fibers to the entire central
nervous system, including the histaminergic tuberomammillary nucleus
(TMN). Dysfunction of the orexin system results in the sleep disorder
narcolepsy, but the role of orexin in physiological sleep–wake
regulation and the mechanisms involved remain to be elucidated. Here we
provide several lines of evidence that orexin A induces wakefulness by
means of the TMN and histamine H
1
receptor (H1R). Perfusion
of orexin A (5 and 25 pmol/min) for 1 hr into the TMN of rats
through a microdialysis probe promptly increased wakefulness for 2
hr after starting the perfusion by 2.5- and 4-fold, respectively,
concomitant with a reduction in rapid eye movement (REM) and non-REM
sleep. Microdialysis studies showed that application of orexin A to the
TMN increased histamine release from both the medial preoptic area and
the frontal cortex by ≈2-fold over the baseline for 80 to 160 min in
a dose-dependent manner. Furthermore, infusion of orexin A (1.5
pmol/min) for 6 hr into the lateral ventricle of mice produced a
significant increase in wakefulness during the 8 hr after starting
infusion to the same level as the wakefulness observed during the
active period in wild-type mice, but not at all in H1R gene knockout
mice. These findings strongly indicate that the arousal effect of
orexin A depends on the activation of histaminergic neurotransmission
mediated by H1R.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.